Results 251 to 260 of about 67,119 (304)

Spatial and multi‐omic profiling reveals pericyte‐derived CCL19 as a key prognostic factor in CNS lymphoma

HemaSphere, Volume 10, Issue 6, June 2026.
Abstract Biological mechanisms underlying clinical heterogeneity in central nervous system lymphoma (CNSL) are largely unknown. While previous studies suggest the chemokine CLL19 as a crucial factor for the formation of CNSL in murine models, its role in human disease remains elusive.
Julia C. Kuehn, Lauritz Miarka, Roman Sankowski, Jurik Mutter, Nicolas N. Neidert, Elena Grabis, Junyi Zhang, Christian Klingler, Fabian Hummel, Lavanya Ranganathan, Sabine Bleul, Eliza M. Lauer, Dieter H. Heiland, Katharina Müller, Hans C. Reinhardt, Sascha Dietrich, Gerald Illerhaus, Louisa von Baumgarten, Stefan Alig, Maximilian Diehn, Bastian E. A. Sajonz, Jürgen Beck, Volker A. Coenen, Marco Prinz, Elisabeth Schorb, Ash A. Alizadeh, Justus Duyster, Peter Reinacher, Florian Scherer   +28 more
wiley   +1 more source

Comprehensive Immunophenotyping of Monocytes and Dendritic Cells Suggests Distinct Pathophysiology in Chronic Fatigue Syndrome and Long COVID. [PDF]

Int J Mol Sci
Petrov S, Bozhkova M, Ivanovska M, Kalfova T, Dudova D, Todorova Y, Dimitrova R, Murdjeva M, Taskov H, Nikolova M, Maes M.   +10 more
europepmc   +1 more source

Rapid complete remission after one cycle of isatuximab-based quadruplet regimen in 1q21-positive primary plasma cell leukemia: a case report. [PDF]

Front Immunol
Pang L, Zhou M, Chen C, Qin P, Yan S, Dong X, Wang R.   +6 more
europepmc   +1 more source

Real-world outcomes of patients with multiple myeloma who reach third-line therapy: a Canadian report. [PDF]

Blood Neoplasia
Louzada ML, Reece D, Venner CP, White D, Su J, Chu MP, Jimenez-Zepeda VH, Mccurdy A, Song K, Mian H, Sebag M, Bergstrom D, Stakiw J, Reiman A, Kotb R, Aslam M, Kaedbey R, Gul E, Sharma S, LeBlanc R.   +19 more
europepmc   +1 more source

CD38^hiCD19^dim cells in lymph nodes predict favorable prognosis in patients with stage III melanoma receiving adjuvant PD-1-blockade. [PDF]

Front Oncol
Ailte I, Chauhan SK, Prasmickaite L, Bassarova AV, Poissonnier A, Feenstra M, Nyakas M, Johannessen B, Ryder T, Hermann R, Frich L, Holth A, Inderberg EM, Jespersen H, Flørenes VA, Kyte JA, Mælandsmo GM, Egeland EV.   +17 more
europepmc   +1 more source

Immunological characteristics of children with autism spectrum disorder and comorbid atopic dermatitis. [PDF]

Front Pediatr
Shi H, Zhang L, Fang F, Zhang Y, Xu X, Gou L, Tang X, Wang H, Cui L, Song H, Shu R, Wang J, You X.   +12 more
europepmc   +1 more source

Characterizing the Fate of Anti‐CS1 Nanobody Displaying Extracellular Vesicles in Multiple Myeloma

Journal of Extracellular Vesicles, Volume 15, Issue 6, June 2026.
ABSTRACT Extracellular vesicles (EVs) are promising delivery vehicles capable of transporting therapeutic agents across biological barriers. However, native EVs primarily accumulate in liver, spleen and lungs, limiting targeted delivery to disease sites.
Michiel De Coster, Lukas Hyka, Sophie De Cock, Sofie Meeussen, Zuowei Wang, Chenggong Tu, Sophie Hernot, Nick Devoogdt, Guido David, Kim De Veirman, Karin Vanderkerken, Eline Menu, Pascale Zimmermann, Elke De Bruyne   +13 more
wiley   +1 more source

Efficacy and Safety of Anti-CD38 Antibody-Containing Triplet Regimens in Frail Patients with Multiple Myeloma. [PDF]

Cancers (Basel)
Iriuchishima H, Saito A, Mihara M, Kanaya S, Yoshizawa R, Isoda A, Matsumoto M.   +6 more
europepmc   +1 more source

Triplet or Quadruplet Regimen Utilization and Overall Survival in Patients Diagnosed With Multiple Myeloma Between 2017 and 2023

eJHaem, Volume 7, Issue 3, June 2026.
ABSTRACT Introduction Multiple myeloma treatment has rapidly evolved, but little is known about the uptake of guideline‐recommended triplet or quadruplet therapy in clinical practice. Methods This retrospective cohort study included adult patients newly diagnosed with multiple myeloma between January 1, 2017, and December 31, 2023, in one health system
Emily R. Wesley, Faiz Anwer, Michael B. Rothberg, Jeffrey D. Kovach, Nicholas J. Casacchia, Brittany Peterre, Ming Wang, Shahzad Raza, Louis S. Williams, Jason Valent, Hamlet Gasoyan   +10 more
wiley   +1 more source

CD38 expression by neonatal human naive CD4+ T cells shapes their distinct metabolic and tolerogenic properties. [PDF]

J Clin Invest
Dwyer LR, DeRogatis AM, Clancy S, Gouirand V, Chien C, Rogers EE, Oltman SP, Jelliffe-Pawlowski LL, van den Broek T, van Wijk F, Lynch SV, Rutishauser RL, Wagner A, Combes AJ, Scharschmidt TC.   +14 more
europepmc   +1 more source